Price Charts

GLENMARK PHARMACEUTICALS LTD.

NSE : GLENMARKBSE : 532296ISIN CODE : INE935A01035Industry : Pharmaceuticals & DrugsHouse : Glenmark
BSE957.50-5.5 (-0.57 %)
PREV CLOSE ( ) 963.00
OPEN PRICE ( ) 961.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21109
TODAY'S LOW / HIGH ( )954.50 968.10
52 WK LOW / HIGH ( )444.3 974.05
NSE958.45-4 (-0.42 %)
PREV CLOSE( ) 962.45
OPEN PRICE ( ) 960.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 958.45 (636)
VOLUME 517943
TODAY'S LOW / HIGH( ) 954.25 968.60
52 WK LOW / HIGH ( )444.3 974
Plot at :
Compare with :
Select Period :
Glenmark Pharmaceuticals Ltd.

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.